InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
DIL | Ann: Diligent Corporation (NS) (“DIL”) – Delisting Update | 14/04/16 | 0 | 335 | |||
|
|||||||
DIL | Ann: SSH Notice - Morgan Stanley and its subsidiaries | 14/04/16 | 0 | 369 | |||
|
|||||||
DIL | Ann: SSH Notice - Credit Suisse Holdings (Australia) Limited | 14/04/16 | 0 | 332 | |||
|
|||||||
DIL | Ann: SSH Notice - UBS Group AG and its related bodies corporate | 14/04/16 | 0 | 421 | |||
|
|||||||
DIL | Ann: SSH: DIL: SSH Notice - UBS Group AG and its related bodies corporate | 14/04/16 | 0 | 322 | |||
|
|||||||
DIL | Ann: Disclosure of Directors/Senior Managers Relevant Interest | 13/04/16 | 0 | 301 | |||
|
|||||||
DIL | Ann: Form 10-K/A | 13/04/16 | 0 | 300 | |||
|
|||||||
DIL | Ann: Diligent provides update on conditions to the Merger | 13/04/16 | 0 | 270 | |||
|
See All Discussions